A structural perspective on the regulation of the epidermal growth factor receptor

E Kovacs, JA Zorn, Y Huang, T Barros… - Annual review of …, 2015 - annualreviews.org
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that plays a critical
role in the pathogenesis of many cancers. The structure of intact forms of this receptor has …

Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels

…, YM Sigal, AD Milstein, JL Garrison, JA Zorn… - Nature …, 2008 - nature.com
In traditional folk medicine, Xanthoxylum plants are referred to as 'toothache trees' because
their anesthetic or counter-irritant properties render them useful in the treatment of pain. …

Turning enzymes ON with small molecules

JA Zorn, JA Wells - Nature chemical biology, 2010 - nature.com
Drug discovery and chemical genetic efforts typically focus on the identification and design
of inhibitors or loss-of-function probes as a means to perturb enzyme function. These tools …

Small-molecule activators of a proenzyme

DW Wolan, JA Zorn, DC Gray, JA Wells - Science, 2009 - science.org
Virtually all of the 560 human proteases are stored as inactive proenyzmes and are strictly
regulated. We report the identification and characterization of the first small molecules that …

Structure− activity relationship study of prion inhibition by 2-aminopyridine-3, 5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro …

BCH May, JA Zorn, J Witkop, J Sherrill… - Journal of medicinal …, 2007 - ACS Publications
2-Aminopyridine-3,5-dicarbonitrile compounds were previously identified as mimetics of
dominant-negative prion protein mutants and inhibit prion replication in cultured cells. Here, we …

Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate

Q Wang, EM Vogan, LM Nocka, CE Rosen, JA Zorn… - Elife, 2015 - elifesciences.org
10.7554/eLife.06074.001 Bruton's tyrosine kinase (Btk), a Tec-family tyrosine kinase, is
essential for B-cell function. We present crystallographic and biochemical analyses of Btk, which …

[HTML][HTML] Crystal structure of the FLT3 kinase domain bound to the inhibitor Quizartinib (AC220)

JA Zorn, Q Wang, E Fujimura, T Barros, J Kuriyan - PloS one, 2015 - journals.plos.org
More than 30% of acute myeloid leukemia (AML) patients possess activating mutations in
the receptor tyrosine kinase FMS-like tyrosine kinase 3 or FLT3. A small-molecule inhibitor of …

Preclinical characterization of relatlimab, a human LAG-3–blocking antibody, alone or in combination with nivolumab

K Thudium, M Selby, JA Zorn, G Rak, XT Wang… - Cancer Immunology …, 2022 - AACR
… JA Zorn reports personal fees from BMS outside the submitted work; and Dr Zorn is an
employee and shareholder of BMS. X. Wang reports personal fees from BMS outside the …

Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice

TN Lombana, S Rajan, JA Zorn, D Mandikian, EC Chen… - MAbs, 2019 - Taylor & Francis
IgA antibodies have broad potential as a novel therapeutic platform based on their superior
receptor-mediated cytotoxic activity, potent neutralization of pathogens, and ability to …

Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation

JA Zorn, H Wille, DW Wolan… - Journal of the American …, 2011 - ACS Publications
Modulating enzyme function with small-molecule activators, as opposed to inhibitors, offers
new opportunities for drug discovery and allosteric regulation. We previously identified a …